Controversies in the therapy of low-grade glioma: when and how to treat.

Abstract

Treatment of low-grade gliomas is one of the most challenging management dilemmas in neuro-oncology. Young age of onset and low rate of growth theoretically favor minimally invasive treatments. Yet, local recurrence and conversion to malignant glioma are the expected outcome within 4-8 years from diagnosis and impose the use of additional therapies, such as… (More)

Topics

Cite this paper

@article{Brandes2002ControversiesIT, title={Controversies in the therapy of low-grade glioma: when and how to treat.}, author={Alba Ariela Brandes and Francesca Vastola and Umberto Basso}, journal={Expert review of anticancer therapy}, year={2002}, volume={2 5}, pages={529-36} }